Bruin Biometrics LLC Logo
Bruin Biometrics LLC Logo

Single-Use-Sensor on Drug Tariff

bbi provizio v3 suh in pack
bbi provizio v3 suh in pack

We are delighted to announce the Provizio ® SEM Scanner Single-Use-Sensors are now available on the NHS England and Wales Drug Tariff.

The NHS Prescription Services produces the Drug Tariff on behalf of the Department of Health and Social Care. This sits under the NHSBSA who manage £35m of NHS spend annually delivering a range of services to NHS contractors, patients and the public. Their purpose is to be a catalyst for better health and their vision is to be the delivery partner of choice for the NHS.

To achieve Drug Tariff listing technologies must demonstrate safety, quality, a positive impact on patient outcomes and ability to reduce the total costs within the patient pathway.

This addition plays a crucial role in ensuring Community Healthcare Professionals have the option of prescribing Provizio SEM Scanner Single-Use-Sensors when scanning patients in their own home to support pressure ulcer prevention.

Provizio SEM Scanner has been proven to help reduce the incidence of pressure ulcers1,2 and has been reported to be cost effective3.

To find out more about how to access the Provizio SEM Scanner solution in your organisation and deploy an objective, targeted and tailored pressure ulcer prevention strategy leading to improved outcomes, please contact our distribution partner, Arjo, here.

  1. Bryant R et al 2022, 2. Ousey K et al 2022, 3. Gefen A et al 2022

Single-Use-Sensor on Drug Tariff

We are delighted to announce the Provizio ® SEM Scanner Single-Use-Sensors are now available on the NHS England and Wales Drug Tariff.

The NHS Prescription Services produces the Drug Tariff on behalf of the Department of Health and Social Care. This sits under the NHSBSA who manage £35m of NHS spend annually delivering a range of services to NHS contractors, patients and the public. Their purpose is to be a catalyst for better health and their vision is to be the delivery partner of choice for the NHS.

To achieve Drug Tariff listing technologies must demonstrate safety, quality, a positive impact on patient outcomes and ability to reduce the total costs within the patient pathway.

This addition plays a crucial role in ensuring Community Healthcare Professionals have the option of prescribing Provizio SEM Scanner Single-Use-Sensors when scanning patients in their own home to support pressure ulcer prevention.

Provizio SEM Scanner has been proven to help reduce the incidence of pressure ulcers1,2 and has been reported to be cost effective3.

To find out more about how to access the Provizio SEM Scanner solution in your organisation and deploy an objective, targeted and tailored pressure ulcer prevention strategy leading to improved outcomes, please contact our distribution partner, Arjo, here.

  1. Bryant R et al 2022, 2. Ousey K et al 2022, 3. Gefen A et al 2022